MGFA has partnered with Bionews to feature the “Myasthenia Gravis News” feed on our MGFA website. We are excited to offer the MG Community this insightful and informative news feed that covers many aspects of living with myasthenia – from research and study results to managing MG, helpful tips, and important news from across the MG World.
Myasthenia Gravis News is a digital platform intended to provide the myasthenia gravis (MG) community with the most recent news and information on MG, as well as first-hand community perspectives from patient and caregiver columnists. All articles on Myasthenia Gravis News are original content produced by in-house writers and editors. Occasionally, BioNews seeks the opinion of outside experts for interviews and Q&As.
Myasthenia Gravis News – The Web’s Daily Resource for Myasthenia Gravis News
- The 3 to 5 minutes that act as music therapy for my brother with MG
by Allen Francis on December 19, 2025 at 3:00 pmI noticed during my most recent video call with my twin brother, Aaron, that he was sorting through a pile of his old-school CDs and cassettes. I teased him about listening to outdated tech. “The cassette player died years ago,” he said. He was checking song titles to see if they were available on YouTube. The post The 3 to 5 minutes that act as music therapy for my brother with MG appeared first on Myasthenia Gravis News.
- Doctors say MG doesn’t cause pain, but my body suggests otherwise
by Sarah Bendiff on December 18, 2025 at 3:00 pmTiredness and exhaustion can often be solved with rest, but constant pain and discomfort steal sleep from my eyes. Doctors keep telling me that myasthenia gravis (MG) doesn’t cause pain, yet my body suggests the opposite. So I keep asking myself: Is MG really painless? I have been living with MG for more than 17 The post Doctors say MG doesn’t cause pain, but my body suggests otherwise appeared first on Myasthenia Gravis News.
- Taking Vyvgart before thymectomy may help improve surgery outcomes
by Steve Bryson, PhD on December 18, 2025 at 3:00 pmAdding a single infusion of Vyvgart (efgartigimod alfa-fcab) to treatment typically given before a thymectomy, or the surgical removal of the thymus gland, results in greater clinical and laboratory improvements in people with myasthenia gravis (MG). That’s according to a small, single-center study in China, which showed that Vyvgart treatment was associated with a shorter The post Taking Vyvgart before thymectomy may help improve surgery outcomes appeared first on Myasthenia Gravis News.
- Finding ways to reduce suffering, even while living with chronic pain
by Mark Harrington on December 17, 2025 at 3:00 pmI haven’t written in a few weeks due to problems with my legs and knees. This has been the most pain I’ve endured since developing avascular necrosis in both hips. The bone destruction was caused by high doses of prednisone prescribed to treat my myasthenia gravis (MG). It led to months of undiagnosed pain, followed The post Finding ways to reduce suffering, even while living with chronic pain appeared first on Myasthenia Gravis News.
- Guest Voice: What living between labels taught me about MG
by Kristina Kelly on December 17, 2025 at 3:00 pmTears gathered in my eyes as I read the disappointing visit summary from a neurology appointment. Being a seronegative myasthenia gravis (MG) patient, I’m leery about seeing neurologists for fear they will dismiss the diagnosis that took years for me to get, but I left the appointment pleasantly surprised when it wasn’t questioned. The appointment The post Guest Voice: What living between labels taught me about MG appeared first on Myasthenia Gravis News.
** MGFA Disclaimer – Please read
Myasthenia Gravis Foundation of America (MGFA) and Bionews, Inc. (specifically Myasthenia Gravis News) have entered into a limited agreement that allows for the MGFA to post a link to Myasthenia Gravis News on the myasthenia.org website. Myasthenia Gravis News is a digital platform intended to provide the myasthenia gravis (MG) community with the most recent news and information on MG, as well as first-hand community perspectives from patient and caregiver columnists. All articles on Myasthenia Gravis News are original content produced by in-house writers and editors. Occasionally, Bionews seeks the opinion of outside experts for interviews and Q&As.
The publishing team at Myasthenia Gravis News is made up of science writers and editors, most of whom have PhDs in the life sciences; veteran journalists; and columnists who are members of the MG community. Together, they attempt to ensure that all content published on Myasthenia Gravis News is relevant, accurate, informative, relatable, and easy to understand.
Each piece of content is carefully selected and written by Bionews writers with the MG community in mind. Sources for news stories and resource pages include peer-reviewed studies, press releases, announcements, interviews, webinars, and conference sessions, among others. All articles go through a stringent fact-checking and editing procedure as part of Bionews’ process to ensure they are accurate, objective, comprehensive, and well-explained.
Columns are written by MG patients and caregivers who provide an intimate look at what it’s like to live with the disease. While columns are largely opinion and perspective pieces, each one still goes through a comprehensive editing and fact-checking process by Bionews editors to ensure clarity, accuracy, and fairness.
Myasthenia Gravis News’ site is strictly a news and information website about the disease. It DOES NOT provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a licensed physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. The information provided is for educational purposes only and does not substitute for professional medical advice.
The content reflects the unique experiences of the authors and is not necessarily the opinion, views, or recommendations of the MGFA. Medical advisors and clinicians associated with or partnering with the MGFA do not peer review articles and information posted on the Myasthenia Gravis News platform or website. MGFA should not be liable for any information, opinions, articles, advice, guidance, or details posted on the Myasthenia Gravis News site. MGFA has posted this platform as a service to the MG community. Please consult with your doctor and healthcare professionals for specific recommendations and advice pertaining to your healthcare/treatment.